DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Cui M, Gao XS, Gu X. , et al.
BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancer.
Oncotarget 2017;
8 (25) 40222-40232
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.